- Home
- EVMN vs JBGS Comparison
EVMN vs JBGS Comparison
Compare EVMN & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVMN | JBGS |
|---|---|---|
| Founded | 2020 | 2016 |
| Country | United States | United States |
| Employees | 48 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 825.5M | 906.3M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | EVMN | JBGS |
|---|---|---|
| Price | $22.86 | $14.43 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 10 | 1 |
| Target Price | ★ $43.88 | $15.00 |
| AVG Volume (30 Days) | 341.8K | ★ 563.4K |
| Earning Date | 06-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.69% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $498,598,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.89 | $13.99 |
| 52 Week High | $33.20 | $24.30 |
Technical Indicators
Market Signals| Indicator | EVMN | JBGS |
|---|---|---|
| Relative Strength Index (RSI) | 45.97 | 44.49 |
| Support Level | $21.39 | $14.17 |
| Resistance Level | $23.08 | $16.07 |
| Average True Range (ATR) | 1.43 | 0.49 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 45.87 | 22.02 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.